Triple

T5793363
Position Surface form Disambiguated ID Type / Status
Subject COMP E128447 entity
Predicate reportsTo P258 FINISHED
Object Management Board of the European Medicines Agency E130570 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Management Board of the European Medicines Agency | Statement: [COMP, reportsTo, Management Board of the European Medicines Agency]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Management Board of the European Medicines Agency
Context triple: [COMP, reportsTo, Management Board of the European Medicines Agency]
  • A. Management Board of the European Medicines Agency chosen
    The Management Board of the European Medicines Agency is the governing body that oversees the agency’s strategy, budget, and overall operations in regulating medicines within the European Union.
  • B. Committee for Medicinal Products for Human Use
    The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.
  • C. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • D. European medicines regulatory authorities
    European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
  • E. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c00845ca68819081a2ce3ecca577f7 completed March 22, 2026, 3:18 p.m.
NER Named-entity recognition batch_69c02a905da88190bc710c6743af2d83 completed March 22, 2026, 5:44 p.m.
NED1 Entity disambiguation (via context triple) batch_69c09824c7f0819095565e0f29b3a508 completed March 23, 2026, 1:32 a.m.
Created at: March 22, 2026, 3:51 p.m.